2019 Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 117 pages | ID: 29C7806F145EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vasomotor Symptoms (Menopausal Hot Flashes). It presents in-depth analysis of Vasomotor Symptoms (Menopausal Hot Flashes) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Vasomotor Symptoms (Menopausal Hot Flashes).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Vasomotor Symptoms (Menopausal Hot Flashes) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Vasomotor Symptoms (Menopausal Hot Flashes)

The research work is prepared through extensive and continuous research on Vasomotor Symptoms (Menopausal Hot Flashes) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Vasomotor Symptoms (Menopausal Hot Flashes) patients are identified
• The report includes panorama of Vasomotor Symptoms (Menopausal Hot Flashes) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Vasomotor Symptoms (Menopausal Hot Flashes) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Region
  2.2.2 Average Enrollment of Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Vasomotor Symptoms (Menopausal Hot Flashes) Treatment, 2019

3. REGION WISE VASOMOTOR SYMPTOMS (MENOPAUSAL HOT FLASHES) CLINICAL TRIALS

3.1 Asia Pacific Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Country
3.2 Europe Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Country
3.3 North America Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Country
3.4 Middle East and Africa Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Country
3.5 South and Central America Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Country

4. VASOMOTOR SYMPTOMS (MENOPAUSAL HOT FLASHES) CLINICAL TRIAL TRENDS

4.1 Start Year wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials
4.2 Phase wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials
4.3 Trial Status wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials
4.4 Trial Type wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials

5. VASOMOTOR SYMPTOMS (MENOPAUSAL HOT FLASHES) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Vasomotor Symptoms (Menopausal Hot Flashes) Trials by Year
5.2 Average Enrollment in Vasomotor Symptoms (Menopausal Hot Flashes) Trials by Phase
5.3 Average Enrollment in Vasomotor Symptoms (Menopausal Hot Flashes) Trials by Status
5.4 Average Enrollment in Vasomotor Symptoms (Menopausal Hot Flashes) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN VASOMOTOR SYMPTOMS (MENOPAUSAL HOT FLASHES) CLINICAL TRIALS

6.1 Vasomotor Symptoms (Menopausal Hot Flashes) Trials by Sponsor Type
6.2 Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Vasomotor Symptoms (Menopausal Hot Flashes) Trials- Phase
7.2 Vasomotor Symptoms (Menopausal Hot Flashes) Trials- Phase
7.3 Vasomotor Symptoms (Menopausal Hot Flashes) Trials- Phase
7.4 Vasomotor Symptoms (Menopausal Hot Flashes) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Figure 7: North America – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Figure 9: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Phase
Figure 10: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Trial Status
Figure 11: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Type
Figure 12: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Sponsor Type
Figure 13: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials by Leading Sponsors
Figure 14: Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Phase
Figure 15: Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Trial Status
Figure 16: Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Type
Figure 17: Vasomotor Symptoms (Menopausal Hot Flashes)- Average Enrolment by Type of Sponsors
Figure 18: Vasomotor Symptoms (Menopausal Hot Flashes)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Table 5: Europe – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Table 7: North America – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Vasomotor Symptoms (Menopausal Hot Flashes) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Phase
Table 15: Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Trial Status
Table 16: Vasomotor Symptoms (Menopausal Hot Flashes) Average Enrollment by Type
Table 17: Vasomotor Symptoms (Menopausal Hot Flashes)- Average Enrolment by Type of Sponsors
Table 18: Vasomotor Symptoms (Menopausal Hot Flashes)- Enrolment by Leading Sponsors